Recombinant Shigella boydii serotype 18 NADH-quinone oxidoreductase subunit K (nuoK)

What are the optimal handling and storage conditions for recombinant nuoK protein?

For maximum stability and activity retention, researchers should follow these protocols:

• Storage: Maintain at -20°C/-80°C for long-term storage

• Buffer composition: Typically supplied in Tris/PBS-based buffer with 6% Trehalose at pH 8.0

• Reconstitution: Briefly centrifuge before opening, then reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL

• Cryoprotection: Add glycerol to a final concentration of 5-50% (commonly 50%) for freeze storage

• Working aliquots: Store at 4°C for up to one week to avoid repeated freeze-thaw cycles

• Quality control: Purity is typically greater than 90% as determined by SDS-PAGE

These handling procedures ensure protein stability while minimizing activity loss during experimental workflows.

What experimental approaches can effectively evaluate nuoK function in the NDH-1 complex?

Multiple complementary techniques have proven valuable for investigating nuoK function:

• Site-directed mutagenesis of conserved residues (particularly Glu-36 and Glu-72) followed by functional assessment

• Enzyme activity assays:

  • dNADH-K₃Fe(CN)₆ reductase activity (measures electron transfer capacity)

  • NADH-DB oxidoreductase activity (evaluates quinone reduction)

  • ATP-driven reverse electron transfer (studies energy coupling)

• Structural integrity assessment:

  • Blue Native PAGE (BN-PAGE) with NADH dehydrogenase activity staining

  • Immunoblotting to verify subunit content

• Membrane potential measurements using fluorescent probes to evaluate proton-pumping capacity

• Relocation mutagenesis to study the positional requirements of functional residues (e.g., relocating conserved glutamates along transmembrane segments)

These approaches collectively provide a comprehensive assessment of how nuoK contributes to NDH-1 assembly, electron transfer capacity, and proton translocation function.

How can researchers optimize expression and purification of recombinant nuoK?

Based on published protocols and membrane protein biochemistry principles:

• Expression system selection:

  • E. coli has been successfully used for nuoK expression

  • Consider specialized strains designed for membrane proteins (C41/C43)

  • Use tunable promoters to control expression levels and prevent toxicity

• Fusion tag strategy:

  • N-terminal His-tag has proven effective for nuoK purification

  • Alternative tags (MBP, SUMO) may improve solubility if needed

• Membrane protein extraction:

  • Test different detergents (DDM, LMNG) for optimal solubilization

  • Consider nanodiscs for maintaining native-like environment

• Purification workflow:

  • Immobilized metal affinity chromatography (IMAC)

  • Size exclusion chromatography for final polishing

  • Quality control via SDS-PAGE and mass spectrometry

The recombinant protein quality can be validated through activity assays comparing to native protein preparations.

How do mutations in conserved glutamic acid residues affect nuoK function?

Research has identified two conserved glutamic acid residues in nuoK that are critical for NDH-1 activity. Extensive mutagenesis studies reveal differential contributions:

These findings demonstrate that Glu-36 plays a critical role in the proton translocation mechanism, while Glu-72 has a supportive but less essential function . Interestingly, when Glu-36 was relocated to nearby positions in the same helix phase, the mutants largely retained activity, suggesting some positional flexibility within the structural constraint of remaining in the same helical face .

What role does the cytoplasmic loop-1 of nuoK play in NDH-1 function?

The short cytoplasmic loop-1 of nuoK, comprising residues Arg-25, Arg-26, and Asn-27, has proven crucial for energy transduction despite its small size. Mutation studies show:

These results indicate that while mutations in loop-1 don't significantly affect NDH-1 assembly, they substantially impact its energy-transducing activity . The highly conserved nature of Arg-25 across species further emphasizes this loop's functional importance, potentially in coordinating conformational changes necessary for proton translocation.

How does nuoK contribute to the proposed proton translocation mechanism?

NuoK appears to play multiple roles in the proton translocation mechanism of NDH-1:

• The highly conserved Glu-36 in TM2 likely participates directly in proton transfer, as its mutation completely abolishes energy transduction while maintaining electron transfer

• NuoK's extensive interactions with NuoN and connection to helix HL of NuoL suggest it forms part of a conformationally coupled network essential for energy transduction

• Recent research indicates that NDH-1/complex I lacking both NuoL and NuoM can still pump protons at H⁺/2e⁻ = 2, suggesting NuoK may be part of a core proton-pumping module

• The conserved charged residues in nuoK likely form part of a proton translocation pathway, with Glu-36 serving as a proton donor/acceptor in the translocation process

Current models suggest that NuoK functions cooperatively with NuoA and NuoJ subunits in the coupling mechanism of NDH-1, contributing to the conformational changes that drive proton translocation across the membrane .

What is the evolutionary relationship between nuoK and the MrpC subunit of multisubunit Na⁺/H⁺ antiporters?

This comparison suggests that while nuoK and MrpC may share some structural features and common ancestry, they have evolved distinct functional properties . The absence in MrpC of the glutamate residues critical for nuoK function indicates divergent mechanisms for ion translocation. This evolutionary relationship provides insights into the diversification of ion-translocating membrane proteins during bacterial evolution.

How might nuoK contribute to pathogenicity or drug resistance in Shigella boydii?

While direct evidence linking nuoK to pathogenicity is limited, several hypotheses merit investigation:

• Energy metabolism and survival: As part of the NDH-1 complex, nuoK contributes to cellular bioenergetics, potentially supporting bacterial survival under stress conditions encountered during infection

• Potential connection to drug resistance: The rising concern about extensively drug-resistant Shigella strains in the United States3 raises questions about how metabolic adaptations might contribute to resistance mechanisms

• Membrane potential maintenance: NuoK's role in proton translocation affects membrane potential, which can influence drug efflux pump efficiency and antibiotic uptake

• Potential as a drug target: The essential nature of NDH-1 for bacterial energy metabolism makes nuoK a potential novel antibiotic target, especially given its divergence from human homologs

Researchers investigating these connections would benefit from studying nuoK expression and mutation patterns in clinical isolates with various resistance profiles, potentially revealing adaptations that enhance survival during antibiotic treatment.

What emerging technologies could advance our understanding of nuoK function?

Several cutting-edge approaches could provide new insights into nuoK function:

• Cryo-electron microscopy to determine high-resolution structures of wild-type and mutant NDH-1 complexes containing nuoK, potentially revealing conformational changes during catalysis

• Hydrogen-deuterium exchange mass spectrometry to map dynamic regions and conformational changes in nuoK during the catalytic cycle

• Single-molecule FRET to track conformational changes in real-time during NDH-1 function

• In silico molecular dynamics simulations to model proton transfer pathways involving nuoK's conserved residues

• CRISPR-based genome editing to study the effects of nuoK mutations in various Shigella strains under different environmental conditions

These approaches would provide mechanistic insights beyond what conventional biochemical assays have revealed, particularly regarding the dynamic aspects of nuoK's role in energy transduction.

How might understanding nuoK function contribute to addressing drug-resistant Shigella infections?

With extensively drug-resistant Shigella strains emerging3, research on nuoK could contribute to new therapeutic approaches:

• Structure-based drug design targeting the interface between nuoK and other NDH-1 subunits could yield novel antibiotics that disrupt energy metabolism

• Understanding how nuoK contributes to bacterial bioenergetics might reveal metabolic vulnerabilities that could be exploited therapeutically

• Comparative analysis of nuoK sequences from resistant and sensitive strains might identify mutations that contribute to adaptation under antibiotic pressure

• Development of inhibitors specifically targeting bacterial respiratory complexes containing nuoK could provide alternatives to traditional antibiotics for which resistance has developed

Given that alternative antibiotics may not be available for patients with severe Shigella infections and compromised immune systems3, developing novel therapeutic approaches targeting fundamental bioenergetic processes represents a promising research direction.